Cardiovascular diseases are irreversible. So, it is crucial to prevent them before they appear

Order your kit today and find out if you are developing a cardiovascular disease before it is too late. 

How we do it

Why we do it 

Who is it for

ABOUT US

SPINOVIT is a spin-off of UCLouvain funded by Vives, B2start and SRIW.

The product and service were developed in the laboratory of Prof. Jean-Luc Balligand, Institute of Experimental and Clinical Research. 

The Project Beta3_LVH funded by the European Union (Horizon 2020), a clinical trial aiming the prevention of heart failure, sustained the developement of this spin-off through the collection of samples in 9 european countries, allowing us to validate the concept developed in SPINOVIT. 

The Walloon Region supported the creation of the spin-off with a First Spin-Off grant and the proof of concept through the clinical trial PICA, demonstrating the predicability of our biomarker. 

UCLouvain IREC.jpg
Vives.jpg
InvestBW.png
SRIW.png
PICA logo final.png
 
 

THE TEAM

2016_irec_vanoverstraeten_001_edited.jpg

Nancy Van Overstraeten

Founder &

Managing Director

2016_irec_balligand_002_edited.jpg

Jean-Luc Balligand

Scientific Advisory Board

22_04_03_spinovit_016_edited.jpg

Arvind

Soni

EPR operator

22_04_03_spinovit_011.jpg

Nathalie Fabian

EPR technician

Hasnaé Boughaleb_2_edited_edited.jpg

Hasnae Boughaleb

PhD student (CT coordinator)

 

TESTIMONIALS

"Finally, something to prevent the cardiovascular diseases"

Guy S.

"Security is just 1 mL of blood away."

Jeanine R.

"I feel safe again"

Albert V.

 

CONTACT

SPINOVIT.jpg

Administration:

SPINOVIT SRL

6, rue Louis de Geer

1348 Louvain-La-Neuve

Belgium

BE 078 078 4375

 

Lab:

57, avenue Hippocrate

1200 Bruxelles

Belgium

Tel: 32 (02) 7645288

Mobile: 32 (477) 134883

contact@spinovit.com

  • Instagram
  • Facebook